FNCH
Finch Therapeutics Group Inc
Price:  
1.80 
USD
Volume:  
629,479.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FNCH WACC - Weighted Average Cost of Capital

The WACC of Finch Therapeutics Group Inc (FNCH) is 7.6%.

The Cost of Equity of Finch Therapeutics Group Inc (FNCH) is 9.75%.
The Cost of Debt of Finch Therapeutics Group Inc (FNCH) is 7.00%.

Range Selected
Cost of equity 8.20% - 11.30% 9.75%
Tax rate 22.10% - 22.30% 22.20%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.8% - 8.3% 7.6%
WACC

FNCH WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.93 1.14
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.20% 11.30%
Tax rate 22.10% 22.30%
Debt/Equity ratio 1 1
Cost of debt 7.00% 7.00%
After-tax WACC 6.8% 8.3%
Selected WACC 7.6%